<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02337101</url>
  </required_header>
  <id_info>
    <org_study_id>18122014</org_study_id>
    <nct_id>NCT02337101</nct_id>
  </id_info>
  <brief_title>Early Intervention Programme for Young Patients (Aged 15 - 30 Years) With Symptoms Following Concussion.</brief_title>
  <official_title>Early Intervention Programme for Impairing Post-concussional Symptoms in Adolescents and Young Adults: Randomised Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central Denmark Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regionshospitalet Hammel Neurocenter</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
      Five - 15 % of patients with concussion continue to experience impairing physical, cognitive&#xD;
      and emotional symptoms longer than 3 months post-injury. Currently, no standardised treatment&#xD;
      is available for patients with persistent post-concussional symptoms (PCS) and systematic&#xD;
      treatment studies remain limited.&#xD;
&#xD;
      Aim:&#xD;
&#xD;
        1. to develop an early intervention programme based on principles from&#xD;
           cognitive-behavioural therapy and graded exercise for young patients with PCS lasting&#xD;
           more than 3 months, and&#xD;
&#xD;
        2. to evaluate the efficacy of this intervention on PCS in a randomised, controlled trial.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      Patients aged 15 - 30 years diagnosed with concussion at hospitals in Central Denmark Region&#xD;
      will be screened for persistent symptoms two months post-injury. Those with impairing&#xD;
      symptoms will be invited to participate in a randomised controlled trial comparing the early&#xD;
      intervention programme with enhanced usual care. We expect to include 120 patients from&#xD;
      2015-2016. Treatment will be interdisciplinary and will begin approximately 3 - 5 months&#xD;
      after concussion. All patients will complete self-report measures at baseline and 3, 6 and 15&#xD;
      months after randomisation. The primary outcome is severity of PCS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background Concussion is an important public health concern. Debilitating and persistent&#xD;
      post-concussional symptoms are associated with considerable long-term sickness and markedly&#xD;
      reduced health-related quality of life in industrialized countries. In Denmark, approximately&#xD;
      25000 people are diagnosed with concussion each year. Although complete resolution of typical&#xD;
      post-concussional symptoms such as headaches, dizziness and fatigue normally occur within the&#xD;
      first days or weeks after a concussion, a significant proportion corresponding to five to15 %&#xD;
      of patients continue to experience symptoms longer than 3 months post-injury. These patients&#xD;
      are at risk of long-term sickness, reduced health-related quality of life as well as&#xD;
      permanently reduced working ability, which is particularly disastrous for adolescents and&#xD;
      young adults. Currently, no standardised treatment is available for patients with persistent&#xD;
      post-concussional symptoms.&#xD;
&#xD;
      The aetiology of persistent post-concussional symptoms is only partly elicited, and no&#xD;
      consensus exists whether post-concussional symptoms constitute a true syndrome linked to&#xD;
      neurobiological disturbances caused by accident or head trauma. Nevertheless, the term&#xD;
      post-concussional syndrome is widely used to describe a set of persistent somatic and&#xD;
      emotional symptoms often observed in concussed individuals. We use the abbreviation 'PCS' as&#xD;
      a purely descriptive term for post-concussional symptoms. The literature suggest, that PCS&#xD;
      are best understood in a complex, multifactorial model, where both biological and&#xD;
      psychological factors contribute to persistent symptoms and associated disability. Moreover,&#xD;
      PCS overlap considerably with symptoms of other trauma-related conditions such as&#xD;
      whiplash-associated disorders and post-traumatic stress disorder. On this background, a&#xD;
      number of trials have tested the effect of various psychosocial interventions, including&#xD;
      cognitive behavioural therapy (CBT), on persistent PCS. Although preliminary, there is some&#xD;
      promising evidence that treatment based on the cognitive-behavioural model may be effective&#xD;
      in treating PCS and prevent permanent suffering and disability.&#xD;
&#xD;
      Some of the cognitive - behavioural mechanisms that have been found to play an important role&#xD;
      in the maintenance of PCS are unhelpful illness perceptions, maladaptive coping strategies&#xD;
      and all-or-nothing behaviour. The all-or-nothing behaviour refers to a behavioural response,&#xD;
      where patients overdo things when they believe symptoms are abating and then spend prolonged&#xD;
      periods recovering when symptoms reappear. Other patients report a gradual restriction of&#xD;
      activity over time, because they fear worsening of symptoms. A promising avenue for treatment&#xD;
      seems to be focusing on making sustainable, gradual increases in levels of activity (in&#xD;
      intensity and / or duration) over time, and to avoid extreme oscillations. This is often&#xD;
      referred to as Graded Exercise Therapy (GET), a treatment that can effectively reduce&#xD;
      impairment and suffering in chronic fatigue and persistent pain and that can be provided by&#xD;
      physiotherapists and hence delivered in a primary care or municipality setting.&#xD;
&#xD;
      Currently, systematic studies of psychosocial interventions for patients with persistent PCS&#xD;
      remain limited. A recent review concludes that more rigorous, large-scale randomised&#xD;
      controlled trials (RCT) evaluating the effectiveness of CBT for persistent PCS are needed.&#xD;
&#xD;
      Aim:&#xD;
&#xD;
        1. to develop an early intervention programme based on CBT and GET principles for young&#xD;
           patients aged 15 - 30 years with PCS lasting more than three months, and&#xD;
&#xD;
        2. to evaluate the efficacy of this intervention programme on PCS in a RCT.&#xD;
&#xD;
      Hypotheses Primary hypothesis Patients in the early intervention group will 6 months after&#xD;
      randomisation report a statistically and clinically significantly greater reduction of&#xD;
      post-concussional symptoms compared to patients who receive enhanced usual care.&#xD;
&#xD;
      Secondary hypotheses&#xD;
&#xD;
        1. Patients in the early intervention group will 6 months after randomisation report a&#xD;
           statistically and clinically significantly higher health related quality of life and&#xD;
           overall daily functioning compared to patients who receive enhanced usual care.&#xD;
&#xD;
        2. Patients in the early intervention group will during the 12 months after treatment have&#xD;
           less consumption of health care (based on register-data) and less illness-related&#xD;
           absence from school or work (based on self-reported data) compared to patients, who&#xD;
           receive enhanced usual care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2015</start_date>
  <completion_date type="Actual">April 2019</completion_date>
  <primary_completion_date type="Actual">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of PCS measured by the Rivermead Post-concussion Symptoms Questionnaire (RPQ)</measure>
    <time_frame>At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.</time_frame>
    <description>Self-rated post-concussion symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life and overall functioning measured by Quality of Life After Brain Injury - Overall Scale (QOLIBRI) and Short Form health status questionnaire from the medical outcome status (SF-36).</measure>
    <time_frame>At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective improvement measured by Patient Global Impression of Change (PGIC)</measure>
    <time_frame>At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Somatisation measured by Bodily Distress Syndrome Checklist (BDS checklist)</measure>
    <time_frame>At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression severity measured by a subscale (SCL-8) of Symptom Check List, 90 items (SCL-90).</measure>
    <time_frame>At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint)and 15 months after baseline.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Anxiety measured by Whitely-8 index</measure>
    <time_frame>At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of health care (extracted from Danish national registers) and degree of illness related absence from school or work (self-reported).</measure>
    <time_frame>15 months after baseline (i.e. after clinical assessment)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported cognitive functioning measured by Behavior Rating Inventory of Executive Function (BRIEF)</measure>
    <time_frame>At baseline (i.e. at clinical assessment) and 6 months after baseline (primary endpoint).</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in illness related cognitions measured by The Brief Illness Perception Questionnaire (B-IPQ)</measure>
    <time_frame>At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.</time_frame>
    <description>Process measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in illness-related behaviours measured by the Behavioural Responses to Illness Questionnaire - short form (BRIQ - short form)</measure>
    <time_frame>At baseline (i.e. at clinical assessment) and 3,6 and 15 months after baseline.</time_frame>
    <description>Process measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in perceived stress measured by Perceived Stress Scale (PSS)</measure>
    <time_frame>At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.</time_frame>
    <description>Process measure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Brain Concussion</condition>
  <condition>Post-Concussion Syndrome</condition>
  <arm_group>
    <arm_group_label>Enhanced Usual Care (EUC)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clinical psychiatric and neurological assessment. Information and advice.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EUC + Early intervention programme</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinical psychiatric and neurological assessment. Information and advice. Individually targeted treatment programme.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Enhanced Usual Care (EUC)</intervention_name>
    <description>All patients will have a brief clinical psychiatric and neurological assessment in order to determine eligibility, and will be provided with information and advice about typical post-concussional symptoms, the typical recovery process and the use of pain medication.</description>
    <arm_group_label>Enhanced Usual Care (EUC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>EUC + Early intervention programme</intervention_name>
    <description>All patients will have a brief clinical psychiatric and neurological assessment in order to determine eligibility, and will be provided with information and advice about typical post-concussional symptoms, the typical recovery process and the use of pain medication.&#xD;
The early intervention programme will be interdisciplinary and will mainly be provided by an occupational therapist and a physiotherapist under supervision of a neuropsychologist. It will be based on psychoeducation and principles from Cognitive Behavioral Therapy and Graded Exercise Therapy and targeted to patients' individual goals.&#xD;
Patients will receive 8 weekly treatment sessions (3 group based and 5 individual sessions). Intervention will start approximately 4-5 months after the concussion.</description>
    <arm_group_label>EUC + Early intervention programme</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Concussion caused by a head trauma according to the diagnostic criteria recommended by&#xD;
             the Danish Consensus Report on Commotio Cerebri 5 within the last 2 - 6 months. The&#xD;
             criteria is based on the diagnostic criteria recommended by the WHO Task Force 1, but&#xD;
             with the amendment, that there must have been a direct contact between the head and an&#xD;
             object in order to rule out acceleration - deceleration traumas.&#xD;
&#xD;
          2. Age between 15 and 30 years at the time of the head trauma.&#xD;
&#xD;
          3. Able to understand, speak and read Danish.&#xD;
&#xD;
          4. A score of 20 or more on the Rivermead Post Concussion Symptoms Questionnaire (RPQ).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Objective neurological findings from neurological examination and / or acute trauma CT&#xD;
             scan, indicating neurological disease or brain damage.&#xD;
&#xD;
          2. Previous concussion leading to persistent post-concussional symptoms within the last&#xD;
             two years.&#xD;
&#xD;
          3. Severe misuse of alcohol, prescription drugs and / or illegal drugs.&#xD;
&#xD;
          4. Multiorgan Bodily Distress Syndrome (multiple somatic symptoms from various body sites&#xD;
             and organ systems not related to the accident).&#xD;
&#xD;
          5. Psychiatric morbidity (Bipolar Disorder, severe Attention Deficit Hyperactivity&#xD;
             Disorder, autism, psychotic disorder (life time)), or other psychiatric illness that&#xD;
             impedes participation in the treatment.&#xD;
&#xD;
          6. Severe neurological disease and / or other medical disease that impedes participation&#xD;
             in the treatment programme.&#xD;
&#xD;
          7. Significant learning and / or reading difficulties or mental retardation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Schr√∂der, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charlotte U Rask, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.functionaldisorders.dk</url>
    <description>Homepage for the Research Clinic for Functional Disorders, Aarhus University Hospital</description>
  </link>
  <link>
    <url>http://www.ungehjerneskadeprojekt.rm.dk</url>
    <description>Homepage (in Danish) for the overarching project in Central Denmark Region focusing on strengthening the treatment options for adolescents and young adults with acquired brain injury or concussion.</description>
  </link>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 8, 2015</study_first_submitted>
  <study_first_submitted_qc>January 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2015</study_first_posted>
  <last_update_submitted>September 25, 2019</last_update_submitted>
  <last_update_submitted_qc>September 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Brain concussion</keyword>
  <keyword>Mild Traumatic Brain Injury</keyword>
  <keyword>Post-concussion symptoms</keyword>
  <keyword>Therapy</keyword>
  <keyword>Randomised controlled trial</keyword>
  <keyword>Cognitive assessment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Post-Concussion Syndrome</mesh_term>
    <mesh_term>Brain Concussion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

